RxDoctor Payments Data

Matt Mathew, MD

Adult Reconstructive Orthopaedic Surgery · Covington, GANPI 1295199073

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (45.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Smith+Nephew at 54.6% of the total. Reporting peaked in 2022 at $7,776 and has fallen 84.6% since, to $1,200 in 2025.

$14,564in general payments, 2019–2025

Across 77 payments — averaging $189.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$8K
  • Stryker$4K
  • Zimmer Biomet$1K
  • Johnson & Johnson$454
  • Medtronic$189
  • Orthofix Medical, Inc.$141
  • plus $209 from 6 others

What the payments were for

  • Travel & lodging$2,98020%
  • Food & beverage$5,02835%
  • Education$6,55645%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,564 in reported general payments places this provider in the 60th percentile of 23 adult reconstructive orthopaedic surgery providers in Georgia.

See all adult reconstructive orthopaedic surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$211,232
Medicare patients
354
Services billed
5,403

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enoxaparin Sodium34$2,663
Diclofenac Sodium57$2,597
Celecoxib172$2,036
Tranexamic Acid118$1,649
Doxycycline Hyclate124$1,108
Oxycodone Hcl225$1,069
Meloxicam456$1,030
Ondansetron Hcl152$930
Pregabalin59$665
Methylprednisolone79$398
Tramadol Hcl124$274
Ibuprofen27$257
Gabapentin21$226
Naproxen17$123
Tizanidine Hcl37$93

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Covington

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →